The CLINICAL And MOLECULAR EFFECTS Of An INSULIN SENSITIZING DRUG: 'PIOGLITAZONE' On PSORIASIS TREATMENT.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Pioglitazone (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
Most Recent Events
- 23 Feb 2011 Biomarkers information updated
- 22 Feb 2011 Actual end date (Aug 2010) added as reported by ClinicalTrials.gov.
- 22 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.